Biofeedback Gait Training for Diabetic Peripheral Neuropathy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help individuals with diabetic peripheral neuropathy (DPN), a condition affecting nerve function in those with diabetes, improve their walking patterns. It will test two types of biofeedback gait training, which provide real-time feedback on walking form, to determine their effectiveness in changing and enhancing walking function. Individuals diagnosed with diabetes and DPN who can walk independently without an assistive device may be suitable for this study. Participants will be randomly assigned to begin with either plantar pressure or propulsion biofeedback training and will complete several walking sessions to evaluate the effects. As an unphased trial, this study offers a unique opportunity to explore innovative treatments that could enhance walking ability.
Do I have to stop taking my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this gait training is safe for individuals with diabetic peripheral neuropathy?
Research has shown that biofeedback gait training is generally safe for people with diabetic peripheral neuropathy. In one study, biofeedback lowered foot pressure without causing new problems for those with diabetes and nerve issues, reducing existing risks without adding new ones.
For plantar pressure biofeedback, another study found a significant decrease in the highest pressure on the feet among diabetic participants. This suggests the technique effectively reduces pressure and is safe, as no side effects were reported.
However, less direct safety information exists for propulsion biofeedback. Most research focuses on biofeedback's effectiveness in different situations, but no specific safety concerns have been identified for this type of training.
Overall, these findings suggest that both types of biofeedback gait training are well-tolerated and pose minimal risk to participants with diabetic peripheral neuropathy.12345Why are researchers excited about this trial?
Researchers are excited about biofeedback gait training for diabetic peripheral neuropathy (DPN) because it offers a novel way to improve walking patterns in people affected by this condition. Unlike traditional treatments that focus on medication or physical therapy exercises, this method uses real-time feedback to help patients adjust their walking mechanics. By using sensors to provide immediate information about plantar pressure and propulsion forces, participants can make instant, informed changes to their gait, potentially leading to improved balance and reduced risk of falls. This technique not only empowers patients with immediate insights into their movement but also aims to retain these benefits over time, which could make a significant difference in their daily mobility and quality of life.
What evidence suggests that this trial's gait training treatments could be effective for diabetic peripheral neuropathy?
Research has shown that biofeedback gait training can help people with diabetic peripheral neuropathy (DPN) improve their walking. In this trial, participants will receive either Plantar Pressure Biofeedback Gait Training followed by Propulsion Biofeedback Gait Training, or the reverse order. One study found that visual feedback helped older adults with DPN reduce foot pressure, making walking safer. Another study demonstrated that biofeedback can lower foot pressure without introducing new injury risks. For propulsion biofeedback, studies have shown it can teach a new walking method that reduces foot pressure, with lasting benefits. Both methods hold promise for helping those with DPN walk better and more safely.12356
Who Is on the Research Team?
Nicole Rendos, PhD
Principal Investigator
Research Scientist
Are You a Good Fit for This Trial?
This trial is for adults aged 45 and older with diabetic peripheral neuropathy (DPN) who can walk independently without aids. Participants must have a diabetes diagnosis, be able to walk on a treadmill, and have had a foot exam in the last six months. People with certain lower limb conditions, surgeries affecting walking, cardiovascular issues that impact safety while walking, or those pregnant cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Evaluation and Baseline Testing
Participants undergo clinical evaluation, gait biomechanics, and gait biofeedback for baseline comparison
Biofeedback Gait Training
Participants with DPN receive biofeedback gait training focusing on plantar pressure and propulsion
Follow-up
Participants are monitored for changes in biomechanics and propulsion after training
What Are the Treatments Tested in This Trial?
Interventions
- Gait Biofeedback
- Plantar Pressure Biofeedback Gait Training
- Propulsion Biofeedback Gait Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Florida Institute for Human and Machine Cognition
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator